NewsDesk @infectiousdiseasenews
On Friday, The U.S. Food and Drug Administration (FDA) warned people to stop using the Empowered Diagnostics CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test.
These tests were distributed with labeling indicating they are authorized by the FDA, but neither test has been authorized, cleared, or approved by the FDA for distribution or use in the United States. The FDA is concerned about the potentially higher risk of false results when using unauthorized tests.
Empowered Diagnostics is recalling the CovClear COVID-19 Rapid Antigen Test and the ImmunoPass COVID-19 Neutralizing Antibody Rapid Test, and the FDA has identified this issue as a Class I recall, the most serious type of recall.
Read more at FDA
- Nicaragua reports the second highest number of malaria cases in the last 20 years in 2021
- African swine fever reported in General Santos City
- Most teens and young adults underestimate sexually transmitted infection risk of oral sex, Better education needed
- Ukraine: Polio vaccination campaign to begin February 1
- Zika virus vaccine candidate shows promising results in preclinical studies
- New York City: Possible leptospirosis among dogs in Williamsburg
- China reports two additional H5N6 avian influenza cases in 2022
- Mexico reports 59% decrease in chickenpox in 2021
